Tumor-preferential induction of immune responses and epidermal cell death in actinic keratoses by ingenol mebutate
The rapid and strong clinical efficacy of the first-in-class, ingenol mebutate, against actinic keratosis (AK) has resulted in its recent approval. We conducted the first comprehensive analysis of the cellular and molecular mode of action of topical ingenol mebutate 0.05% gel in both AK and uninvolv...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
9 September 2016
|
| In: |
PLOS ONE
Year: 2016, Jahrgang: 11, Heft: 9 |
| ISSN: | 1932-6203 |
| DOI: | 10.1371/journal.pone.0160096 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1371/journal.pone.0160096 Verlag, kostenfrei, Volltext: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0160096 
|
| Verfasserangaben: | Steffen Emmert, Holger A. Haenssle, John R. Zibert, Margarete Schön, Andreas Hald, Maria H. Hansen, Thomas Litman, Michael P. Schön |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1566799120 | ||
| 003 | DE-627 | ||
| 005 | 20230814093940.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180102s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1371/journal.pone.0160096 |2 doi | |
| 035 | |a (DE-627)1566799120 | ||
| 035 | |a (DE-576)496799126 | ||
| 035 | |a (DE-599)BSZ496799126 | ||
| 035 | |a (OCoLC)1340985607 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Emmert, Steffen |d 1969- |e VerfasserIn |0 (DE-588)133299341 |0 (DE-627)540509078 |0 (DE-576)274009226 |4 aut | |
| 245 | 1 | 0 | |a Tumor-preferential induction of immune responses and epidermal cell death in actinic keratoses by ingenol mebutate |c Steffen Emmert, Holger A. Haenssle, John R. Zibert, Margarete Schön, Andreas Hald, Maria H. Hansen, Thomas Litman, Michael P. Schön |
| 264 | 1 | |c 9 September 2016 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 02.01.2018 | ||
| 520 | |a The rapid and strong clinical efficacy of the first-in-class, ingenol mebutate, against actinic keratosis (AK) has resulted in its recent approval. We conducted the first comprehensive analysis of the cellular and molecular mode of action of topical ingenol mebutate 0.05% gel in both AK and uninvolved skin of 26 patients in a phase I, single-center, open-label, within-patient comparison. As early as 1 day after application, ingenol mebutate induced profound epidermal cell death, along with a strong infiltrate of CD4+ and CD8+ T-cells, neutrophils, and macrophages. Endothelial ICAM-1 activation became evident after 2 days. The reaction pattern was significantly more pronounced in AK compared with uninvolved skin, suggesting a tumor-preferential mode of action. Extensive molecular analyses and transcriptomic profiling of mRNAs and microRNAs demonstrated alterations in gene clusters functionally associated with epidermal development, inflammation, innate immunity, and response to wounding. Ingenol mebutate reveals a unique mode of action linking directly to anti-tumoral effects. Trial Registration: ClinicalTrials.gov NCT01387711 | ||
| 650 | 4 | |a Lesions | |
| 650 | 4 | |a Biopsy | |
| 650 | 4 | |a Cell death | |
| 650 | 4 | |a Dermis | |
| 650 | 4 | |a Epidermis | |
| 650 | 4 | |a Gene expression | |
| 650 | 4 | |a Inflammation | |
| 650 | 4 | |a MicroRNAs | |
| 700 | 1 | |a Hänßle, Holger |e VerfasserIn |0 (DE-588)1074971531 |0 (DE-627)832791733 |0 (DE-576)443174598 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t PLOS ONE |d San Francisco, California, US : PLOS, 2006 |g 11(2016,9) Artikel-Nummer e0160096, 20 Seiten |h Online-Ressource |w (DE-627)523574592 |w (DE-600)2267670-3 |w (DE-576)281331979 |x 1932-6203 |7 nnas |a Tumor-preferential induction of immune responses and epidermal cell death in actinic keratoses by ingenol mebutate |
| 773 | 1 | 8 | |g volume:11 |g year:2016 |g number:9 |a Tumor-preferential induction of immune responses and epidermal cell death in actinic keratoses by ingenol mebutate |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1371/journal.pone.0160096 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0160096 |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20180102 | ||
| 993 | |a Article | ||
| 994 | |a 2016 | ||
| 998 | |g 1074971531 |a Hänßle, Holger |m 1074971531:Hänßle, Holger |d 910000 |d 911300 |e 910000PH1074971531 |e 911300PH1074971531 |k 0/910000/ |k 1/910000/911300/ |p 2 | ||
| 999 | |a KXP-PPN1566799120 |e 2991539739 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"relHost":[{"disp":"Tumor-preferential induction of immune responses and epidermal cell death in actinic keratoses by ingenol mebutatePLOS ONE","name":{"displayForm":["Public Library of Science"]},"pubHistory":["1.2006 -"],"recId":"523574592","note":["Schreibweise des Titels bis 2012: PLoS ONE","Gesehen am 20.03.19"],"origin":[{"publisherPlace":"San Francisco, California, US ; Lawrence, Kan.","dateIssuedDisp":"2006-","publisher":"PLOS ; PLoS","dateIssuedKey":"2006"}],"title":[{"title_sort":"PLOS ONE","title":"PLOS ONE"}],"physDesc":[{"extent":"Online-Ressource"}],"part":{"year":"2016","volume":"11","text":"11(2016,9) Artikel-Nummer e0160096, 20 Seiten","issue":"9"},"id":{"issn":["1932-6203"],"zdb":["2267670-3"],"eki":["523574592"]},"language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"corporate":[{"role":"isb","display":"Public Library of Science"}]}],"title":[{"title_sort":"Tumor-preferential induction of immune responses and epidermal cell death in actinic keratoses by ingenol mebutate","title":"Tumor-preferential induction of immune responses and epidermal cell death in actinic keratoses by ingenol mebutate"}],"person":[{"role":"aut","family":"Emmert","display":"Emmert, Steffen","given":"Steffen"},{"role":"aut","family":"Hänßle","display":"Hänßle, Holger","given":"Holger"}],"language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"id":{"eki":["1566799120"],"doi":["10.1371/journal.pone.0160096"]},"origin":[{"dateIssuedKey":"2016","dateIssuedDisp":"9 September 2016"}],"note":["Gesehen am 02.01.2018"],"recId":"1566799120","name":{"displayForm":["Steffen Emmert, Holger A. Haenssle, John R. Zibert, Margarete Schön, Andreas Hald, Maria H. Hansen, Thomas Litman, Michael P. Schön"]}} | ||
| SRT | |a EMMERTSTEFTUMORPREFE9201 | ||